# CYCLOSPORINE
> **ANDA209811** · Abbreviated New Drug Application (Generic) · Sponsor: DEVA HOLDING AS · Approved 2024-05-21
## Drug
- **FDA Application Number:** ANDA209811
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CYCLOSPORINE
- **Generic name:** CYCLOSPORINE
- **Active ingredients:** CYCLOSPORINE
- **Dosage form:** EMULSION
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** DEVA HOLDING AS
- **Manufacturer:** Devatis Inc.
- **First approval:** 2024-05-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209811)
---
*AI Analytics · CC0 1.0*